RxDoctor Payments Data

Seshu Rao, MD

Interventional Cardiology · Topeka, KSNPI 1194757815

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,537 of the $6,175 with a category attached, or 73.5%. 11 manufacturers reported payments, led by Medtronic at 59.9% of the total. 2025 is the largest year on record at $2,195, 6.2 times the $352 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in KS, where the typical reported total is $8,846.

$6,175in general payments, 2019–2025

Across 208 payments — averaging $29.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Boston Scientific$1K
  • Abbott$453
  • Cardiovascular Systems Inc.$425
  • Abiomed$193
  • Shockwave Medical, Inc$109
  • plus $170 from 5 others

What the payments were for

  • Travel & lodging$1,63927%
  • Food & beverage$4,53773%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,175 in reported general payments places this provider in the 35th percentile of 55 interventional cardiology providers in Kansas.

See all interventional cardiology providers in Kansas

Medicare billing

Part B allowed, 2024
$288,676
Medicare patients
1,407
Services billed
3,018

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban27$27,418
BrilintaTicagrelor34$22,567
Repatha SureclickEvolocumab27$16,938
ClopidogrelClopidogrel Bisulfate262$2,174
Metoprolol Succinate138$1,225
Atorvastatin Calcium152$977
Isosorbide Mononitrate ErIsosorbide Mononitrate49$826
Cilostazol21$521
Losartan Potassium43$400
Metoprolol Tartrate112$346
Pantoprazole Sodium23$335
Rosuvastatin Calcium29$311
Nitroglycerin28$305
Carvedilol59$276
Chlorthalidone18$252

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Topeka

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →